tocilizumab

WHO prequalifies 1st monoclonal antibody, tocilizumab, to treat COVID-19

eAwaz Medicine

Washington – Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19. To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations (three vials, each with a different quantity) of the product prequalified today. The three prequalified products are manufactured by the …